skip to Main Content

New Drug May Improve Quality Of Life And Survival In Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Scientists at the University of Sheffield have found a new drug adrenomedullin-2 receptor antagonists which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer and relapsed breast cancer.

The researchers founded the spin-out company Modulus Oncology, along with a team of experienced biotech entrepreneurs, to fast-track the drug into clinical testing within two years. Read more . . .

Back To Top